Next Investors logo grey

These Australian entrepreneurs have crafted the world’s first pot-infused gin

Published 09-NOV-2018 16:13 P.M.

|

4 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Melbourne-based startup, The Cannabis Company, has launched the beverage you never realised you were thirsting for — purportedly, the world’s first cannabis-infused gin distilled with terpenes.

The Myrcene Hemp Gin, which sold out of its first release in just three days, is crafted in Victoria’s Healesville region and takes its name from the most abundant terpene in cannabis, which is also found in hops, mangoes and bay leaves.

Terpenes are essential oils that live in the same glands as the cannabinoids called trichomes. Terpenes give cannabis its distinctive flavour and aroma.

Unsurprisingly, they’re instrumental in the gastronomic market that’s been on the rise in the retail pot industry. Besides affecting fragrance and taste, there’s evidence suggesting that they may also accentuate cannabis’s effects (although they're not exclusive to pot). The sour diesel marijuana strain - which has a zesty yet diesel-like aroma - is known for it's mood-boosting effects.

Terpenes work with other cannabinoids such as CBD and THC, creating a union of compounds that achieve better results as a group than they would in isolation – an outcome known as “the entourage effect”.

According to The Cannabis Company, when used in high concentrations, myrcene is valued as a dietary health and wellness supplement, and is said to “produce joyful and euphoric effects alongside an overall feeling of relaxation”. It can also ease chronic pain and inflammation.

The Cannabis Company is the brainchild of PhD biochemist Dr. David Stapleton, entrepreneur Richard Jameson, and a marketing guru Cormac Sheehan. Its aim is simple: legalise the stuff.

While the company’s current product range is free from psychoactive substances, it plans to release products which include CBD in the longer term. “Hemp foods are just the tip of the iceberg,” its website maintains.

The gin itself is produced in column stills in order to create a “lighter, more refined gin”, with terpenes then added in the distillation process.

The Mercyne Hemp Gin

So, what does it actually taste like?

Very far from bong-water, from the sounds of it. According to the company, “bubblegum aromas blend with lavender, pine forest and sage,” and “soft tones of violet interact on the palate with woodland flavours of rosemary and resin, cloves and woody spices.”

“With a long complex finish and a rich mouthfeel”, the product “represents the marriage of past and future."

These kinds of florid descriptions recall the elevated prose of wine connoisseurship, turning the traditional association of pot with seediness on its head.

This hinges on something that’s pivotal not just to the success of the fast-growing cannabis beverage market and the interconnected edibles space, but also to a broader mainstream pot culture that’s recently emerged in parallel with an increasingly permissive legislative landscape.

This is a culture that maintains that pot can make for a tasty treat. Echoing this, beverage giant names like Constellation Brands (NYSE:STZ), Molson Coors Brewing Company (NYSE:TAP), Diageo (NYSE:DEO), and even Coca-Cola (NYSE:KO), have this year been making considerable investments in developing cannabis-infused drinks.

This is a potentially lucrative space to be playing in. According to analysts at Cannaccord Genuity, drinks infused with marijuana-derived compounds could become a US$600 million market in the US alone within the next four years, outpacing the growth of other categories of retail cannabis products.

But descriptors reminiscent of wine copywriting take this a step further, suggesting that pot-injected beverages (or pot in general) now have a distinguished place in the world of high culture — or old-world elegance meets urban sophistication, as the "marriage of past and future" theme suggests.

Humphrey Bogart and Ingrid Bergman in Casablanca

All of this, in turn, is very much removed from the stigma and reefer madness scaremongering that underpins the history of cannabis prohibition and legalisation — not to mention the hippy overtones that modern pot branding seems to be doing away with.

“We’ve got nothing against hippies,” Sheehan explained in an interview with SBS, “But the public image of the cannabis plant is still stuck in the 60s. It’s unfortunate, as this plant has a million applications as a food, a medicine, a textile, even as a sustainable fire-resistant building material. Yet it still suffers from considerable stigma, the result being that millions of Aussies are missing out on how it can benefit their lives.”

Notably, hemp itself became legal in Australia in November last year.

Something else worth considering here is that there are numerous restrictions around what you can say and do with labelling on hemp-featured products.

“They brought in a new bylaw that said you can't say the word ‘cannabis’ on a product,” Sheehan noted. “This meant that we wasted a couple of thousand dollars on packaging because we had to get it relabelled, so some of our products are CannaCo instead of the Cannabis Company.”

“We had to be very careful with the copy on the labels because we can’t make any direct reference to anything to do with cannabis culture, so we have to dance around a bit, saying ‘Mary Jane’ or ‘That Which Cannot Be Named’.”

The first 300 bottles of the gin produced in Healesville, Victoria, sold out in three days. The company has now released a second batch of gin which is available to pre-order for AU$99.00.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.